Immune Response News and Research

RSS

Researchers discover a sustainable approach for drug development

Although several people think of medicines as purely synthetic compounds, nature is an important element of most of the medications humans depend on.

4 Feb 2022

Researchers discover how long-term memory T cells are formed after Covid-19

Exposure to SARS-CoV-2 by infection or vaccination generates immune cells that provide long-term immunity. These long-lived memory T cells play a key role in preventing severe cases of Covid-19. Researchers at the University of Zurich have now discovered how these memory T cells form.

3 Feb 2022

MIT researchers develop new way to deliver RNA in a capsule

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles. Now, a team of MIT researchers has developed a way to deliver RNA in a capsule that can be swallowed, which they hope could help make people more receptive to them.

1 Feb 2022

Meat eating, less gut bacteria, more immune cell subsets in the blood linked to multiple sclerosis

Eating more meat, having less of certain bacteria in the gut, and more of certain immune cells in the blood, all link with multiple sclerosis, reports a team of researchers led by UConn Health and Washington University School of Medicine.

27 Jan 2022

Novel study to identify how immune receptors recognize unique chemical signals on fungal cells

A new study tries to pinpoint the crucial first step in how human immune systems recognize fungal invaders.

From University of Exeter 27 Jan 2022

Omicron variant found to be less effective at blocking cellular defense mechanism against viruses

A new study by researchers from the University of Kent and the Goethe University Frankfurt shows that the SARS-CoV-2 Omicron variant is less effective than Delta at blocking a cellular defense mechanism against viruses, the so-called “interferon response”.

25 Jan 2022

COVID-19 vaccines prompt the body to make long-lasting T cells against different variants

Scientists at La Jolla Institute for Immunology (LJI) have found that four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2.

25 Jan 2022

Study examines cadmium’s toxicological effect on the immune response and biomineralization of larval flounder

Acidification of seawater poses a significant hazard to both calcifying and non-calcifying marine species, primarily impacting the immune system and biomineralization.

20 Jan 2022

Virologists identify a dual-action drug effective against SARS-CoV-2

A research team discovered a new dual attack mode of action while working on the development of a therapeutic candidate against SARS-CoV-2 infections.

20 Jan 2022

Researchers discover a key mechanism used by Zika virus to evade cell’s antiviral response

The world knows SARS-CoV-2 intimately now, but there are more than 200 virus species capable of infecting humans and causing disease.

19 Jan 2022

Study analyzes the impact of T cells from common cold coronaviruses against SARS-CoV-2 exposure

A new study has illustrated that people having higher levels of T cells from common cold coronaviruses are not likely to get infected with SARS-CoV-2.

13 Jan 2022

Omicron variant hampers the effectiveness of vaccines and monoclonal antibodies, study shows

The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries.

From Institut Pasteur 10 Jan 2022

T cell responses likely to protect against Omicron, says research

T cells are thought to be effective in setting up an immune response against Omicron despite the substantially higher mutations compared to earlier variants of concern.

7 Jan 2022

Blocking function of blood-clotting protein prevents bone loss from gum disease in mice

Blocking function of a blood-clotting protein prevented bone loss from periodontal (gum) disease in mice, according to research led by scientists at the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health.

24 Dec 2021

Immune Response News and Research

Researchers discover a sustainable approach for drug development

Researchers discover how long-term memory T cells are formed after Covid-19

MIT researchers develop new way to deliver RNA in a capsule

Meat eating, less gut bacteria, more immune cell subsets in the blood linked to multiple sclerosis

Novel study to identify how immune receptors recognize unique chemical signals on fungal cells

Omicron variant found to be less effective at blocking cellular defense mechanism against viruses

COVID-19 vaccines prompt the body to make long-lasting T cells against different variants

Study examines cadmium’s toxicological effect on the immune response and biomineralization of larval flounder

Virologists identify a dual-action drug effective against SARS-CoV-2

Researchers discover a key mechanism used by Zika virus to evade cell’s antiviral response

Study analyzes the impact of T cells from common cold coronaviruses against SARS-CoV-2 exposure

Omicron variant hampers the effectiveness of vaccines and monoclonal antibodies, study shows

T cell responses likely to protect against Omicron, says research

Blocking function of blood-clotting protein prevents bone loss from gum disease in mice

Breakthrough infections enhance immune response to COVID-19 variants

Multiple changes in brain cells during embryonic development may contribute to schizophrenia

Driving up the immune response at tumor site may help boost immunotherapy

Immune cells utilize the body’s fat stores to combat infection, says study

Study uncovers an immune evasion mechanism of SARS-CoV-2

People previously infected by Chikungunya virus may develop partial immunity to Mayaro virus

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics